The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.EBI
Showa Pharmaceutical University
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.EBI
Showa Pharmaceutical University
Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease.EBI
Showa Pharmaceutical University
Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.EBI
Showa Pharmaceutical University
A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.EBI
Showa Pharmaceutical University
Zamamiphidins B and C, Manzamine-Related Alkaloids from an EBI
Showa Pharmaceutical University
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone.EBI
Showa Pharmaceutical University
Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands.EBI
Showa Pharmaceutical University
Structural basis for the selective inhibition of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) by a selenium-containing inhibitor with chloro-aminopyridine as a basic group.EBI
Showa Pharmaceutical University
Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action.EBI
Showa Pharmaceutical University